Toggle Offcanvas
...
 
Sorafenib Tenders

Sorafenib Tenders

View Sorafenib tenders, RFPs and contracts. Bid on readily available Sorafenib tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Sorafenib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Sorafenib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Sorafenib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Sorafenib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

7 Live Notices for Sorafenib Tenders

Showing 1 to 7

Tender Invitation For The Supply Of Sorafenib Tablet 200Mg
country Hong Kong
posting date30 Jul 2025
deadline10 Sep 2025
Open House Drug Discount Agreements Sorafenib, Atc L01Ex02
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Open House Drug Rebate Agreements Sorafenib, Atc L01Ex02
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Medicines Containing The Active Substance Sorafenib (Atc: L01Ex02)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Pharmaceutical Discount Agreements For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Aug 2024
deadline03 Aug 2026
Medicines Containing The Active Substance Sorafenib (Atc: L01Ex02)
country Germany
posting date12 Aug 2024
deadline31 Jul 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sorafenib (L01Ex02) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date06 Aug 2024
deadline31 Jul 2026

Share Share this page